Targeting sickle cell pathobiology and pain with novel transdermal curcumin is a research paper published in PNAS Nexus (2025). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: RO1s HL147562
NIH
Grant: CA263806
NIH
Grant: U18 EB029354
A.P. Giannini Foundation Fellowship
Grant: K99 AT012494
NCATS NIH HHS
Grant: UL1 TR001863
NHLBI NIH HHS
Grant: R01 HL147562
NCCIH NIH HHS
Grant: U24 AT012868
NCI NIH HHS
Grant: R01 CA263806
National Institutes of Health
Grant: 1U18EB029354-01
Treating pain in sickle cell disease by means of focused ultrasound neuromodulation
National Institutes of Health
Grant: 1K99AT012494-01A1
Nutrition-based interventions to ameliorate pain in sickle cell disease
National Institutes of Health
Grant: 3R01HL147562-05S1
Role of mast cell traps in Alzheimer's disease
National Institutes of Health
Grant: 1U24AT012868-01
Sickle Cell Disease Pain Analgesia And Integrative Network
National Institutes of Health
Grant: 5R01CA263806-03
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
FJC Foundation
Susan Samueli Scholar Award
CBER Product Horizon Research Funds
Vascarta Inc.
Keywords